Aimmune Therapeutics, Inc is a startup based in the United States, most recent round Pre-ipo.
Aimmune Therapeutics, Inc is a company headquartered in the United States. Its most recent tracked round is Pre-ipo.
Aimmune Therapeutics, Inc is a biopharmaceutical company developing desensitization treatments for food allergies.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.